Imidocarb dihydrochloride monohydrate is a novel antiprotozoal agent specifically used in veterinary medicine for the treatment and prevention of various protozoal diseases, including babesiosis, piroplasmosis, trypanosomiasis, eperythrozoonosis, anaplasmosis, and theileriosis. It is administered via intramuscular or subcutaneous injection, offering rapid absorption, wide tissue distribution, and a quick peak plasma concentration within one hour. Due to its low dosage requirements, convenient administration, short treatment duration, and low propensity for resistance development, it is widely utilized as a veterinary-specific drug.